Lexeo Therapeutics, Inc. (LXEO) Operating Leases (2022 - 2023)
Lexeo Therapeutics' Operating Leases history spans 2 years, with the latest figure at $8.1 million for Q3 2023.
- For Q3 2023, Operating Leases changed N/A year-over-year to $8.1 million; the TTM value through Sep 2023 reached $8.1 million, changed N/A, while the annual FY2022 figure was $9.0 million, N/A changed from the prior year.
- Operating Leases for Q3 2023 was $8.1 million at Lexeo Therapeutics, down from $9.0 million in the prior quarter.
- Across five years, Operating Leases topped out at $9.0 million in Q4 2022 and bottomed at $8.1 million in Q3 2023.